
APDN
NSCApplied DNA Sciences Inc.
Industrials•Security & Protection Services
Watchlists:
Last updated: Sunday 20th July 2025
5.04
-0.11 (-2.14%)
Prev Close:5.15
Open:5.33
Bid:5.07
Ask:5.08
52 Week Range
4.352,655.00
Volume:108,032
Mkt Cap:2 M
33
MarketXLS Rank ®
Weak Hold
Price Target
$5.80
+15.1%
Financial Statements
APDN - Income Statement (Annual)
Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 | Sep-15 | |
---|---|---|---|---|---|---|---|---|---|---|
Accrued Preferred Stock Dividends | -110105.0 | 2842.0 | 309607.0 | |||||||
Allowances For Construction | 13 M | |||||||||
Depreciation And Amortization | 696425.0 | 1 M | 1 M | 767025.0 | 285730.0 | 390424.0 | 547796.0 | 887305.0 | 706496.0 | 3 M |
Development Expense | 3 M | |||||||||
Excise Taxes | 720900.0 | |||||||||
General And Administrative Expense | 11 M | 13 M | 15 M | 13 M | 10 M | -516988.0 | -528234.0 | -552240.0 | -490745.0 | -490915.0 |
Gross Profit Margin (profit Margin After CGS) | 1 M | 6 M | 5 M | 4 M | 1 M | -877613.0 | -1 M | -1 M | 3 M | 9 M |
Impairment Of Capital Assets | 821741.0 | -253977.0 | ||||||||
Interest Expense Non Operating | -75332.0 | -7200.0 | -13675.0 | 115830.0 | -31875.0 | |||||
Interest Expense Operating | -138604.0 | -8136.0 | ||||||||
Minority Interests | 95785.0 | 75857.0 | 2168.0 | -8003.0 | 1685.0 | 9323.0 | ||||
Misc Other Special Charges | 9 M | 855042.0 | 18 M | -2 M | -378075.0 | -1 M | -37005.0 | -38388.0 | 12875.0 | -28313.0 |
Net Income (loss) | -7 M | -10 M | -8 M | -14 M | -13 M | -14 M | -16 M | -18 M | -12 M | -12 M |
Net Income Common Stockholders | -7 M | -10 M | -8 M | -14 M | -13 M | -14 M | -16 M | -18 M | -12 M | -12 M |
Net Income Continuous Operations | -7 M | -10 M | -8 M | -14 M | -13 M | -14 M | -16 M | -18 M | -12 M | -12 M |
Net Non Operating Interest Income Expense | 176301.0 | 75332.0 | 7200.0 | 13675.0 | -115830.0 | 31875.0 | ||||
Net Operating Interest Income Expense | -162432.0 | -9615.0 | 2763.0 | 11004.0 | -23468.0 | |||||
Non Recurring Operation Expense | 106923.0 | |||||||||
Normalized Income | -7 M | |||||||||
Operating Income | -14 M | -11 M | -14 M | -13 M | -13 M | -15 M | -16 M | -18 M | -12 M | -11 M |
Operating Income Before Depreciation (EBITDA) | -6 M | -12 M | -13 M | -12 M | -12 M | -8 M | -11 M | -12 M | -11 M | -11 M |
Operating Expense | 15 M | 16 M | 19 M | 18 M | 14 M | -14 M | -14 M | -16 M | -15 M | -16 M |
Other Gand A | 11 M | 13 M | 15 M | 13 M | 10 M | -516988.0 | -528234.0 | -552240.0 | -490745.0 | -490915.0 |
Other Impairment Of Capital Assets | 536355.0 | 157221.0 | ||||||||
Other Operating Expenses | 722332.0 | 663513.0 | 587346.0 | 565597.0 | 585189.0 | |||||
Otherunder Preferred Stock Dividend | -110105.0 | 2842.0 | 309607.0 | |||||||
Preferred Stock Dividends | -110105.0 | 2842.0 | 309607.0 | |||||||
Promotion And Advertising | 124036.0 | 185115.0 | 13 M | 283621.0 | 55558.0 | -133000.0 | -287156.0 | -315266.0 | -245281.0 | -158373.0 |
Realized Capital Gain | -3 M | |||||||||
Rent And Landing Fees | -528234.0 | -552240.0 | -490745.0 | -490915.0 | ||||||
Research Expense | 4 M | 4 M | 4 M | 4 M | 3 M | 3 M | 3 M | 2 M | 4 M | 3 M |
Salaries And Wages | 572293.0 | 1 M | 3 M | 2 M | 1 M | -1 M | -1 M | -3 M | -2 M | -4 M |
Selling And Marketing Expense | 124036.0 | 185115.0 | 13 M | 283621.0 | 55558.0 | 10 M | 11 M | 13 M | 11 M | 13 M |
Selling Expense | 10 M | 11 M | 13 M | 11 M | 13 M | |||||
Total Income Available For Interest Expense (EBIT) | -7 M | -13 M | -14 M | -13 M | -13 M | -9 M | -12 M | -13 M | -12 M | -12 M |
Total Revenues | 3 M | 13 M | 18 M | 9 M | 2 M | 5 M | 748040.0 | 249348.0 | 4 M | 9 M |
Total Expenses | 17 M | 24 M | 32 M | 19 M | 14 M | -15 M | -16 M | -18 M | -16 M | -17 M |
Total Revenue | 3 M | 13 M | 18 M | 9 M | 2 M | 5 M | 4 M | 5 M | 3 M | 5 M |
Write Down | 980842.0 | |||||||||
Amord | 68976.0 | 129441.0 | -153260.0 | -179351.0 | -483823.0 | -254284.0 | -96891.0 | |||
Avgshs | 5288.0 | 871.0 | 597.0 | 461.0 | 261.0 | 61.0 | 49.0 | 43.0 | 39.0 | 31.0 |
Avgshsdt | 5288.0 | 871.0 | 597.0 | 461.0 | 261.0 | 96.0 | 64.0 | 43.0 | 39.0 | 15.0 |
Basiceps | -1365.0 | -11400.0 | -13950.0 | -31050.0 | -49800.0 | |||||
Basicepscont | -1365.0 | -11400.0 | -13950.0 | -31050.0 | -49800.0 | |||||
Cor | 2 M | 8 M | 13 M | 5 M | 827823.0 | -877613.0 | -1 M | -1 M | -1 M | -384269.0 |
Depamor | 696425.0 | 1 M | 1 M | 767025.0 | 285730.0 | 390424.0 | 547796.0 | 887305.0 | 706496.0 | 3 M |
Dileps | -1365.0 | -11400.0 | -13950.0 | -31050.0 | -49800.0 | -145350.0 | -240000.0 | -294000.0 | -306000.0 | -378000.0 |
Dilepscont | -1365.0 | -11400.0 | -13950.0 | -31050.0 | ||||||
Intinc | 176301.0 | 75332.0 | 116786.0 | |||||||
Netincdisc | -7 M | -10 M | -8 M | -14 M | -13 M | -14 M | -16 M | -18 M | -12 M | -12 M |
Othincexp | -9 M | -855042.0 | 6 M | 2 M | 378075.0 | 1 M | 37005.0 | 38388.0 | -12875.0 | 28313.0 |
Othspecchg | 720900.0 | |||||||||
Pretaxinc | -7 M | -10 M | -8 M | -14 M | -13 M | -9 M | -12 M | -13 M | -12 M | -12 M |
Resdev | 4 M | 4 M | 4 M | 4 M | 3 M | 3 M | 3 M | 2 M | 4 M | 3 M |
Sga | 11 M | 13 M | 28 M | 13 M | 10 M | 10 M | 11 M | 13 M | 11 M | 13 M |
Shsout | 52 M | 912.0 | 860.0 | 499.0 | 377.0 | 232.0 | 50.0 | 50.0 | 43.0 | 40.0 |
Specincchg | -821741.0 | -106923.0 | 253977.0 | -980842.0 | ||||||
Taxprov | -11000.0 | -3 M | -3 M | -1 M | -3 M | 15000.0 | -4 M | -21 M |